Bio-Rad Laboratories Research and Development Expenses 2010-2023 | BIO
Bio-Rad Laboratories annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Bio-Rad Laboratories research and development expenses for the quarter ending December 31, 2023 were $0.064B, a 3.48% decline year-over-year.
- Bio-Rad Laboratories research and development expenses for the twelve months ending December 31, 2023 were $0.247B, a 3.68% decline year-over-year.
- Bio-Rad Laboratories annual research and development expenses for 2023 were $0.247B, a 3.68% decline from 2022.
- Bio-Rad Laboratories annual research and development expenses for 2022 were $0.257B, a 1.44% decline from 2021.
- Bio-Rad Laboratories annual research and development expenses for 2021 were $0.261B, a 19.69% increase from 2020.
| Bio-Rad Laboratories Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $247 |
| 2022 | $257 |
| 2021 | $261 |
| 2020 | $218 |
| 2019 | $203 |
| 2018 | $199 |
| 2017 | $250 |
| 2016 | $206 |
| 2015 | $193 |
| 2014 | $220 |
| 2013 | $211 |
| 2012 | $209 |
| 2011 | $178 |
| 2010 | $172 |
| 2009 | $164 |
| Bio-Rad Laboratories Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $64 |
| 2023-09-30 | $44 |
| 2023-06-30 | $65 |
| 2023-03-31 | $75 |
| 2022-12-31 | $66 |
| 2022-09-30 | $67 |
| 2022-06-30 | $64 |
| 2022-03-31 | $60 |
| 2021-12-31 | $59 |
| 2021-09-30 | $64 |
| 2021-06-30 | $63 |
| 2021-03-31 | $74 |
| 2020-12-31 | $57 |
| 2020-09-30 | $60 |
| 2020-06-30 | $52 |
| 2020-03-31 | $49 |
| 2019-12-31 | $57 |
| 2019-09-30 | $48 |
| 2019-06-30 | $50 |
| 2019-03-31 | $48 |
| 2018-12-31 | $53 |
| 2018-09-30 | $49 |
| 2018-06-30 | $47 |
| 2018-03-31 | $49 |
| 2017-12-31 | $76 |
| 2017-09-30 | $62 |
| 2017-06-30 | $63 |
| 2017-03-31 | $49 |
| 2016-12-31 | $57 |
| 2016-09-30 | $50 |
| 2016-06-30 | $50 |
| 2016-03-31 | $49 |
| 2015-12-31 | $56 |
| 2015-09-30 | $43 |
| 2015-06-30 | $47 |
| 2015-03-31 | $47 |
| 2014-12-31 | $59 |
| 2014-09-30 | $53 |
| 2014-06-30 | $56 |
| 2014-03-31 | $53 |
| 2013-12-31 | $56 |
| 2013-09-30 | $53 |
| 2013-06-30 | $52 |
| 2013-03-31 | $50 |
| 2012-12-31 | $56 |
| 2012-09-30 | $48 |
| 2012-06-30 | $52 |
| 2012-03-31 | $53 |
| 2011-12-31 | $41 |
| 2011-09-30 | $45 |
| 2011-06-30 | $48 |
| 2011-03-31 | $43 |
| 2010-12-31 | $45 |
| 2010-09-30 | $43 |
| 2010-06-30 | $44 |
| 2010-03-31 | $40 |
| 2009-12-31 | $45 |
| 2009-09-30 | $40 |
| 2009-06-30 | $42 |
| 2009-03-31 | $37 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $8.140B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.261B | 23.87 |
| Stryker (SYK) | United States | $123.641B | 29.61 |
| Medtronic (MDT) | Ireland | $110.900B | 15.70 |
| Boston Scientific (BSX) | United States | $106.819B | 34.02 |
| EssilorLuxottica (ESLOY) | France | $100.527B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.760B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.671B | 27.50 |
| ResMed (RMD) | United States | $32.010B | 30.05 |
| Terumo (TRUMY) | Japan | $25.312B | 35.75 |
| Koninklijke Philips (PHG) | Netherlands | $25.036B | 19.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.603B | 15.72 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $11.278B | 50.01 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.977B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.808B | 36.57 |
| Lantheus Holdings (LNTH) | United States | $5.398B | 13.45 |
| Haemonetics (HAE) | United States | $4.886B | 24.17 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.199B | 12.73 |
| Prestige Consumer Healthcare (PBH) | United States | $3.500B | 16.55 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $2.820B | 15.65 |
| Neogen (NEOG) | United States | $2.781B | 26.75 |
| Green Thumb Industries (GTBIF) | United States | $2.736B | 54.19 |
| TG Therapeutics (TGTX) | United States | $2.677B | 75.30 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.647B | 0.00 |
| ICU Medical (ICUI) | United States | $2.641B | 23.31 |
| Agios Pharmaceuticals (AGIO) | United States | $1.904B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.711B | 50.14 |
| Verano Holdings (VRNOF) | United States | $1.693B | 0.00 |
| InMode (INMD) | Israel | $1.553B | 8.25 |
| Warby Parker (WRBY) | United States | $1.536B | 0.00 |
| Owens & Minor (OMI) | United States | $1.431B | 12.47 |
| AdaptHealth (AHCO) | United States | $1.263B | 9.41 |
| National Vision Holdings (EYE) | United States | $1.174B | 37.35 |
| AtriCure (ATRC) | United States | $1.069B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.951B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.950B | 0.00 |
| Evolus (EOLS) | United States | $0.790B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.734B | 15.61 |
| Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
| Quanterix (QTRX) | United States | $0.645B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.634B | 14.91 |
| PetIQ (PETQ) | United States | $0.572B | 18.69 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| Jin Medical (ZJYL) | China | $0.515B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.498B | 0.00 |
| Surmodics (SRDX) | United States | $0.463B | 28.97 |
| ZimVie (ZIMV) | United States | $0.459B | 39.12 |
| Biote (BTMD) | United States | $0.448B | 8.59 |
| OraSure Technologies (OSUR) | United States | $0.382B | 12.29 |
| Cerus (CERS) | United States | $0.370B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.364B | 0.00 |
| Zynex (ZYXI) | United States | $0.339B | 46.44 |
| MacroGenics (MGNX) | United States | $0.274B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 27.11 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 15.22 |
| Omeros (OMER) | United States | $0.217B | 0.00 |
| Veru (VERU) | United States | $0.195B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.190B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.171B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.154B | 74.00 |
| InterCure (INCR) | Israel | $0.141B | 23.77 |
| FitLife Brands (FTLF) | United States | $0.140B | 22.57 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.110B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.83 |
| MariMed (MRMD) | United States | $0.099B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| Chimerix (CMRX) | United States | $0.094B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.093B | 0.00 |
| Brainsway (BWAY) | Israel | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.073B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.067B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.81 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Exagen (XGN) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |